Attached files
file | filename |
---|---|
EX-10.40 - AMENDMENT TO EXCLUSIVE DISTRIBUTION AND LICENSING AGREEMENT BY AND BETWEEN WIZE - Mawson Infrastructure Group Inc. | f10k2020ex10-40_wizepharma.htm |
EX-32.2 - CERTIFICATION - Mawson Infrastructure Group Inc. | f10k2020ex32-2_wizepharma.htm |
EX-32.1 - CERTIFICATION - Mawson Infrastructure Group Inc. | f10k2020ex32-1_wizepharma.htm |
EX-31.2 - CERTIFICATION - Mawson Infrastructure Group Inc. | f10k2020ex31-2_wizepharma.htm |
EX-31.1 - CERTIFICATION - Mawson Infrastructure Group Inc. | f10k2020ex31-1_wizepharma.htm |
EX-21.1 - SUBSIDIARIES OF THE COMPANY - Mawson Infrastructure Group Inc. | f10k2020ex21-1_wizepharma.htm |
EX-4.2 - DESCRIPTION OF SECURITIES - Mawson Infrastructure Group Inc. | f10k2020ex4-2_wizepharma.htm |
10-K - ANNUAL REPORT - Mawson Infrastructure Group Inc. | f10k2020_wizepharmainc.htm |
EXHIBIT 23.1
Fahn Kanne & Co. Head Office 32 Hamasger Street Tel-Aviv 6721118, ISRAEL PO Box 36172, 6136101
T +972 3 7106666 F +972 3 7106660 www.gtfk.co.il |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated March 1, 2021, with respect to the consolidated financial statements included in the Annual Report of Wize Pharma, Inc. on Form 10-K for the year ended December 31, 2020. We consent to the incorporation by reference of said report in the Registration Statement of Wize Pharma, Inc. on Form S-8 (File No. 333-224146).
/s/ FAHN KANNE & CO. GRANT THORNTON ISRAEL
Tel Aviv, Israel
March 1, 2021
Certified Public Accountants Fahn Kanne & Co. is the Israeli member firm of Grant Thornton International Ltd. |
1